Metastasis

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention

Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer

Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases

FAPI PET/CT in Various FAP-Related Disease Patients

Somatostatin Receptor PET/CT in SSTR-Related Disease Patients

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC

Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Radiofrequency Ablation of Lung Tumors

68Ga-FAPI PET/CT in Patients With Various Types of Cancer

Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung

Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway

Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis

Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy